Safety and efficay of a Coleus forskohlii formulatio
Not Applicable
- Conditions
- obesity
- Registration Number
- JPRN-UMIN000008224
- Lead Sponsor
- DHC Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
- Subjects who have an inappropriate clinical history for efficacy and safety assessment in the study (such as drug abuse, alcoholism, and the disease of heart, liver, kidney, lungs, eye, blood etc) and who is taking any drugs. - Subjects judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint was safety for phase I. Adverse events.
- Secondary Outcome Measures
Name Time Method Feasibility for phase II study.